Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryClinical TrialClinical Development

PUBLISHER: Grand View Research | PRODUCT CODE: 1790458

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1790458

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Clinical Trial Equipment & Ancillary Solutions Market Summary

The global clinical trial equipment & ancillary solutions market size was valued at USD 3.21 billion in 2024 and is projected to reach USD 6.88 billion by 2033, growing at a CAGR of 8.92% from 2025 to 2033. The growth of the market is due to the increasing complexity and globalization of clinical trials, which demand highly specialized, protocol-specific equipment and logistics support.

The rapid adoption of decentralized and hybrid trial models requires remote monitoring devices, wearable sensors, and home-use diagnostic kits, significantly expanding the scope of ancillary services. The transformation of clinical trial models, especially the increase of decentralized and hybrid trials, has significantly raised the demand for specialized equipment and support services that facilitate remote, site-less, and home-based research settings. The traditional model, which relied heavily on centralized trial sites, is being replaced by more patient-focused approaches, requiring remote monitoring devices, mobile health kits, wearables, and courier-enabled logistics for biological samples. For example, the U.S. FDA has promoted decentralized clinical trials (DCTs) through its 2023 draft guidance, urging sponsors to adopt digital health technologies and remote care tools to enhance patient access and data quality. These developments are leading CROs and sponsors to acquire reliable, temperature-sensitive packaging, validated medical devices for home use, and real-time tracking systems to oversee equipment shipments across different regions. This shift has transformed the role of clinical trial equipment suppliers from passive vendors into active, integrated service partners responsible for ensuring regulatory compliance, proper calibration, and delivery schedules aligned with study protocols.

Additionally, government and non-profit funding organizations are increasingly supporting early-stage research, translational medicine, and investigator-initiated trials, all of which depend on timely access to ancillary trial supplies. Initiatives like the NIH's All of Us Research Program and the European Union's Horizon Europe framework are expanding the boundaries of patient cohort diversity and precision diagnostics, which require adaptive and flexible equipment supply strategies. For example, Horizon Europe allocates nearly USD 111.49 billion (€95 billion) toward science and innovation through 2027, with multiple projects focused on personalized medicine, wearable monitoring, and telehealth-integrated clinical trials. These initiatives generate demand for site-ready kits, cloud-connected monitoring devices, and digitally traceable shipping for reagents and biologics.

Global Clinical Trials Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical trial equipment & ancillary solutions market report based on type, phase and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Sourcing
    • Procurement
    • Equipment
    • Ancillaries
    • Rental
    • Equipment
    • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment servicing
    • Others
  • Others
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68039-533-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
  • 4.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Sourcing
    • 4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Procurement
      • 4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Equipment
        • 4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Ancillaries
        • 4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Rental
      • 4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Equipment
        • 4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Ancillaries
        • 4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Supply/Logistics
    • 4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transportation
      • 4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Packaging
      • 4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Calibrations
      • 4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Equipment servicing
      • 4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
  • 5.3. Global Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis by Type, Phase

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. Ancillare, LP
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Imperial CRS, Inc.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Service benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Woodley Equipment Company Ltd.
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Service benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Thermo Fisher Scientific, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Service benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Parexel International (MA) Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Service benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Emsere
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Service benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Quipment SAS
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Service benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. IRM
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Service benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Marken
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Service benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Myonex
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Service benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Yourway
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Service benchmarking
      • 7.3.11.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-533-5

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 16 France clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 31 China clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 35 India clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)
  • Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Clinical trial equipment & ancillary solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Clinical trial equipment & ancillary solutions market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
  • Fig. 22 Clinical trial equipment & ancillary solutions market, by type segment: Market share, 2025 & 2033
  • Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
  • Fig. 39 Clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
  • Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional market: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 US clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Sweden clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Australia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial equipment & ancillary solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Market participant categorization
  • Fig. 98 Heat map analysis
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!